IDStewardship

  • Home
  • Articles
  • LEARN ANTIBIOTICS
  • Study Guide
  • Resources
  • Q&A
  • #ASPchat
  • Contributors
  • About

Ali Vyain, Pharm.D.

Ali Vyain

Ali Vyain, Pharm.D. obtained her Doctor of Pharmacy (Pharm.D.) from Nova Southeastern University in May 2015. Following graduation she completed a post-graduate year 1 (PGY-1) pharmacy practice residency at Oklahoma State University Medical Center.

Currently, Dr. Vyain is pursuing a specialty residency in HIV Ambulatory Care/Clinical Pharmacogenetics at the University Of Houston College Of Pharmacy (UHCOP). At the UHCOP, she serves as a Clinical Instructor and continues to pursue her passion of serving the HIV population through clinical practice, research, and teaching/precepting future pharmacists.

After her PGY2, Dr. Vyain desires to work as a clinical pharmacy specialist in HIV/AIDS pharmacotherapy as well as promote the profession of pharmacy through teaching for a school of pharmacy. Her main areas of interest are HIV/AIDS, infectious diseases, and ambulatory care.

Articles

Advice On The Personnel Placement Service At ASHP Midyear

Reality Versus Expectation: Being A PGY1 Pharmacy Resident

LEARN ANTIBIOTICS

STEWARD PINS

Subscribe

Sign up for the monthly newsletter!

We will never spam you. We want you to like us. By clicking the Subscribe button, you accept the Terms of Service and Privacy Policy.

Categories

  • COVID-19
  • Healthcare At Large
  • Infectious Diseases & Antimicrobial Stewardship
  • Pharmacy News
  • Reality Check
  • Residency & Training
  • Facebook
  • Google+
  • Instagram
  • LinkedIn
  • Pinterest
  • Tumblr
  • Twitter
  • YouTube

Recent Posts

  • Five Common Financial Mistakes To Avoid As A Pharmacist
  • Five Things I Learned From #ASMicrobe 2022 – Through Twitter
  • Going From A To Z With Antibiotic Toxicities
  • IV Push Antibiotics: Practical Insights & Tips From The Front Lines
  • Reality Versus Expectation: Being a Specialty Pharmacist

COVID-19

Musical Chairs & The ABCs of SARS-CoV-2 Monoclonal Antibodies

Musical Chairs & The ABCs of SARS-CoV-2 Monoclonal Antibodies

A Comparison Of Paxlovid Versus Molnupiravir: The First Oral COVID Antivirals

A Comparison Of Paxlovid Versus Molnupiravir: The First Oral COVID Antivirals

Five Things For Pharmacists To Know About The Omicron Variant

Five Things For Pharmacists To Know About The Omicron Variant

Molnupiravir – The New COVID Antiviral Named After Thor’s Hammer

Molnupiravir – The New COVID Antiviral Named After Thor’s Hammer

Tags

antibiotic Antibiotics antimicrobial stewardship bcps beta-lactam cancer Chemotherapy Clinical Controversies clinical pharmacist clinical pharmacy community pharmacist Critical Care emergency medicine Emoji Game fellowship figure1 Hepatitis C hospital pharmacist hospital pharmacy Infectious Disease infectious diseases Lifestyle MRSA NAPLEX Natural Disaster oncology pharmacist one-on-one penicillin allergy PGY2 Pharmacy Famous pharmacy fellowship Pharmacy Job pharmacy practice pharmacy residency pharmacy school pharmacy student Pharmacy technician PK-PD Compass Predatory Journals Rapid Diagnostic Testing social media student pharmacist study table transplant Zika

Penicillin Allergy Assessment Certificate Program

Recent

  • Five Common Financial Mistakes To Avoid As A Pharmacist
  • Five Things I Learned From #ASMicrobe 2022 – Through Twitter
  • Going From A To Z With Antibiotic Toxicities
  • IV Push Antibiotics: Practical Insights & Tips From The Front Lines
  • Reality Versus Expectation: Being a Specialty Pharmacist

Search

Copyright 2016-2020 By Charlie Rose, LLC © · IDStewardship.com · Copyright · Privacy Policy · Terms · Contact